Home › GlaxoSmithKline opts to hold on to HIV business
 

Keywords :   


GlaxoSmithKline opts to hold on to HIV business

2015-05-06 15:04:10| Biotech - Topix.net

British-based drugmaker GlaxoSmithKline has opted to keep its stand-alone HIV business as it set out its strategy following the completion of its recent deal with Switzerland's Novartis. GSK said it has cancelled an initial public offering of its HIV business, ViiV Healthcare, opting instead to retain its full holding in the joint venture with equity partners Pfizer and Shiongi.

Tags: business hold hiv glaxosmithkline

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.05Is China's bubble tea bubble about to burst?
17.05Eastern North Pacific Tropical Weather Outlook
17.05Atlantic Tropical Weather Outlook
17.05Business locked in expensive AI 'arms race'
17.05Is the move to electric cars running out of power?
17.05Pornhub partners with UK child abuse fighting charity
16.05CFTC charges Agridime and its co-founders with a fraudulent cattle scheme
16.05Baleage: Advantageous for first cutting hay
More »